Unusual Age-Dependent Behavior of Leukocytes Telomere Length in Friedreich's Ataxia
- PMID: 39235665
- DOI: 10.1002/mds.29976
Unusual Age-Dependent Behavior of Leukocytes Telomere Length in Friedreich's Ataxia
Abstract
Background: Friedreich ataxia (FRDA) is an autosomal recessive neurodegenerative disorder caused by an expanded GAA repeat in the first intron of the FXN gene.
Objective: The aim of this study was to analyze leukocyte telomeres length (LTL) in FRDA to verify the possible relationships between LTL and disease progression. We investigated LTL in a cohort of FRDA biallelic patients (n = 61), heterozygous (n = 29), and age-matched healthy subjects (n = 87).
Methods: LTL was measured by real-time polymerase chain reaction quantitative analysis (qPCR).
Results: The results showed that before 35 years of age, leukocyte telomeres were longer in patients than in controls, whereas the reverse applies in patients above 36 years of age. Interestingly, LTL was greater than controls at any age in heterozygous subjects. This picture mirrors what has been previously observed in vitro in FRDA cultured fibroblasts, showing significantly longer telomeres at early passages because of activation of an alternative lengthening of telomeres (ALT)-like mechanism, but showing accelerated telomere shortening as population doubling increases. GAA1 repeat length is positively correlated with the LTL and negatively correlated with the age at blood sampling. The relationship of LTL with clinical parameters (cardiomyopathy, diabetes, dependence on a wheelchair) was also analyzed. Significantly shorter leukocyte telomeres were associated with the presence of cardiomyopathy, but not with diabetes and the dependence on a wheelchair.
Conclusions: Overall, the present study indicates that telomere length analysis in FRDA may be a relevant biomarker for following the stages of the disease. © 2024 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
Keywords: Friedreich Ataxia; Leukocyte Telomere Length; Neurodegenerative diseases; Oxidative stress.
© 2024 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
References
-
- Parkinson MH, Boesch S, Nachbauer W, Mariotti C, Giunti P. Clinical features of Friedreich's ataxia: classical and atypical phenotypes. J Neurochem 2013;126(Suppl 1):103–117. https://doi.org/10.1111/jnc.12317
-
- Reetz K, Dogan I, Costa AS, et al. Biological and clinical characteristics of the European Friedreich's ataxia consortium for translational studies (EFACTS) cohort: a cross‐sectional analysis of baseline data. Lancet Neurol 2015;14(2):174–182. https://doi.org/10.1016/S1474-4422(14)70321-7
-
- Cook A, Giunti P. Friedreich's ataxia: clinical features, pathogenesis and management. Br Med Bull 2017;124(1):19–30. https://doi.org/10.1093/bmb/ldx034
-
- Smith FM, Kosman DJ. Molecular defects in Friedreich's ataxia: convergence of oxidative stress and cytoskeletal abnormalities. Front Mol Biosci 2020;7:569293. https://doi.org/10.3389/fmolb.2020.569293
-
- Lynch DR, Schadt K, Kichula E, McCormack S, Lin KY. Friedreich ataxia: multidisciplinary clinical care. J Multidiscip Healthc 2021;14:1645–1658. https://doi.org/10.2147/JMDH.S292945
MeSH terms
Grants and funding
- Department of Health's National Institute for Health Research Biomedical Research Centre's
- National Institute for Health Research University College London
- project 739510/European Reference Network for Rare Neurological Diseases
- MR/N028767/1/Medical Research Council Centre for Neurodevelopmental Disorders
- 2018/2019 grants/Sapienza University of Rome
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
